Translocation (X;20)(q13.1;q13.3) as a primary chromosomal finding in two patients with myelocytic disorders

Cancer Genetics and Cytogenetics

Volumn 141, Issue 2, 2003, Pages 169-174

  Gray, Brian A ^a   Cornfield, Dennis ^a,b   Bent Williams, Angela ^a   Zori, Robert T ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; HYDROXYUREA; IDARUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; CHROMOSOME 20; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION X; CLINICAL FEATURE; CLONING; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; LABORATORY TEST; MYELODYSPLASIA; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; TREATMENT OUTCOME; X CHROMOSOME;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, X; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; POLYCYTHEMIA VERA; TRANSLOCATION, GENETIC;

EID: 0037372233     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00764-1     Document Type: Article

References (35)

1. Kristoffersson U., Mitelman F. X-chromosome involvement in neoplasia. Clin Genet. 23:1983;214.
2. Dewald G.W., Brecher M., Travis L.B., Stupca P.J. Twenty-six patients with hematologic disorders and X chromosome abnormalities. Frequent idic(X)(q13) chromosomes and Xq13 anomalies associated with pathologic ringed sideroblasts. Cancer Genet Cytogenet. 42:1989;173-185.
3. Michaux L., Wlodarska I., Mecucci C., Hernandez J.M., Van Orshoven A., Michaux J.L., Van den Berghe H. Characterization by chromosome painting of balanced and unbalanced X chromosome translocations in myelodysplastic syndromes. Cancer Genet Cytogenet. 82:1995;17-22.
4. Fisch P., Forster A., Sherrington P.D., Dyer M.J., Rabbitts T.H. The chromosomal translocation t(X;14)(q28;q11) in T-cell pro-lymphocytic leukaemia breaks within one gene and activates another. Oncogene. 8:1993;3271-3276.
5. Wong K.F., Hayes K.J., Huh Y.O., Albitar M., Glassman A.B. Translocation (X;10)(p10;p10). a rare but nonrandom chromosomal abnormality in acute leukemia of myeloid differentiation Cancer Genet Cytogenet. 86:1996;153-155.
6. Borkhardt A., Repp R., Haas O.A., Leis T., Harbott J., Kreuder J., Hammermann J., Henn T., Lampert F. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene. 14:1997;195-202.
7. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., Lister T.A., Bloomfield C.D. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues. report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997 Histopathology. 36:2000;69-86.
8. Huret JL, Le Minor S, Dorkeld F, Dessen P, Bernheim A. Atlas of genetics and cytogenetics in oncology and haematology, an interactive database. Available at http://www.infobiogen.fr/services/chromcancer . Accessed July 24, 2002.
9. Mitelman F, Johansson B, Mertens F. Mitelman database of chromosome aberrations in cancer. Available at http://cgap.nci.nih.gov/Chromosomes/Mitelman . Accessed July 24, 2002.
10. Dewald G.W., Pierre R.V., Phyliky R.L. Three patients with structurally abnormal X chromosomes, each with Xq13 breakpoints and a history of idiopathic acquired sideroblastic anemia. Blood. 59:1982;100-105.
11. Mackinnon W.B., Michael P.M., Webber L.M., Garson O.M. Isodicentric X chromosomes involving the Xq13 breakpoint in myelodysplasia and acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 30:1988;43-52.
12. Rack K.A., Chelly J., Gibbons R.J., Rider S., Benjamin D., Lafreniere R.G., Oscier D., Hendriks R.W., Craig I.W., Willard H.F. Absence of the XIST gene from late-replicating isodicentric X chromosomes in leukaemia. Hum Mol Genet. 3:1994;1053-1059.
13. Kristiansen M., Langerod A., Knudsen G.P., Weber B.L., Borresen-Dale A.L., Orstavik K.H. High frequency of skewed X inactivation in young breast cancer patients. J Med Genet. 39:2002;30-33.
14. Buller R.E., Sood A.K., Lallas T., Buekers T., Skilling J.S. Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst. 91:1999;339-346.
15. Harrison C.J., Cuneo A., Clark R., Johansson B., Lafage-Pochitaloff M., Mugneret F., Moorman A.V., Secker-Walker L.M. Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia. 12:1998;811-822.
16. Mitelman F. Recurrent chromosome aberrations in cancer. Mutat Res. 462:2000;247-253.
17. McDonell N., Ramser J., Francis F., Vinet M.C., Rider S., Sudbrak R., Riesselman L., Yaspo M.L., Reinhardt R., Monaco A.P., Ross F., Kahn A., Kearney L., Buckle V., Chelly J. Characterization of a highly complex region in Xq13 and mapping of three isodicentric breakpoints associated with preleukemia. Genomics. 64:2000;221-229.
18. Wang P.W., Eisenbart J.D., Cordes S.P., Barsh G.S., Stoffel M., Le Beau M.M. Human krml (Mafb). cDNA cloning, genomic structure, and evaluation as a candidate tumor suppressor gene in myeloid leukemias Genomics. 59:1999;275-281.
19. Roulston D., Espinosa R.D., Stoffel M., Bell G.I., Le Beau M.M. Molecular genetics of myeloid leukemia. identification of the commonly deleted segment of chromosome 20 Blood. 82:1993;3424-3429.
20. Quintrell N., Lebo R., Varmus H., Bishop J.M., Pettenati M.J., Le Beau M.M., Diaz M.O., Rowley J.D. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells. Mol Cell Biol. 7:1987;2267-2275.
21. Hollings P.E. Molecular heterogeneity at the breakpoints of smaller 20q deletions. Genes Chromosomes Cancer. 11:1994;21-28.
22. Asimakopoulos F.A., White N.J., Nacheva E., Green A.R. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood. 84:1994;3086-3094.
23. Chen Z., Richkind K., Roherty S., Velasco J., Lytle C., Brothman A.R., Sandberg A.A. A group of previously not recognized cytogenetic abnormalities in myeloid hematological malignancies. Cancer Genet Cytogenet. 113:1999;162-165.
24. Weis J., DeVito V., Allen L., Linder D., Magenis E. Translocation X;10 in a case of congenital acute monocytic leukemia. Cancer Genet Cytogenet. 16:1985;357-364.
25. Pui C.H., Raimondi S.C., Murphy S.B., Ribeiro R.C., Kalwinsky D.K., Dahl G.V., Crist W.M., Williams D.L. An analysis of leukemic cell chromosomal features in infants. Blood. 69:1987;1289-1293.
26. Raimondi S.C., Kalwinsky D.K., Hayashi Y., Behm F.G., Mirro J. Jr., Williams D.L. Cytogenetics of childhood acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 40:1989;13-27.
27. Otokida K., Yoshida H., Mizunuma Y., Yamada M., Hiramori K. Multiple myeloma associated with amyloidosis and t(1;20)(q21;q11) translocation. Tohoku J Exp Med. 162:1990;363-365.
28. Jorgenson K.F., Antoun G.R., Childs C.C., Felix E.A., Cork A., Yee G., Trujillo J.M., Pinkel D.P., Zipf T.F. 8;20 chromosomal translocation in a case of acute leukemia. cytogenetic, immunophenotypic, ultrastructural, and molecular characteristics. Cancer Genet Cytogenet. 52:1991;1-9.
29. Jarosova M., Scudla V., Bacovsky B., Indrak K., Souskova I., Behal K. Two cases of t(9;20) in multiple myeloma. Cancer Genet Cytogenet. 90:1996;106-108.
30. Heerema N.A., Maben K.D., Bernstein J., Breitfeld P.P., Neiman R.S., Vance G.H. Dicentric (9;20)(p11;q11) identified by fluorescence in situ hybridization in four pediatric acute lymphoblastic leukemia patients. Cancer Genet Cytogenet. 92:1996;111-115.
31. Ishida F., Kitano K., Ichikawa N., Ito T., Kohara Y., Taniguchi T., Motokura T., Kiyosawa K. Hairy cell leukemia with translocation (11;20)(q13;q11) and overexpression of cyclin D1. Leuk Res. 23:1999;763-765.
32. Betts D.R., Greiner J., Feldges A., Niggli F.K. A further case of a t(11;20)(p15;q11.2) translocation in an acute myeloid leukemia (FAB M2). J Pediatr Hematol Oncol. 20:1998;91-93.
33. Ahuja H.G., Felix C.A., Aplan P.D. The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion. Blood. 94:1999;3258-3261.
34. Mitelman F., Prigogina E.L., Fleischman E.W., Frenkel M.A., Garwicz S., Heim S., Ilyinskaya G.W., Kristoffersson U., Mandahl N., Volkova M.A. A new specific chromosomal rearrangement, t(11;20)(p15;q11), in myeloblastic leukemia with maturation. Leukemia. 2:1988;430-432.
35. Cuneo A., Mecucci C., Kerin S., van den Berghe E., Dal Cin P., Van Orshoven A., Rodhain J., Bosly A., Michaux J.L., Martiat P. Multipotent stem cell involvement in megakaryoblastic leukemia. cytologic and cytogenetic evidence in 15 patients Blood. 74:1989;1781-1790.